New research from Memorial Sloan Kettering Cancer Center (MSK) finds a potential therapeutic opportunity in regulatory T cells’ resilience to the loss of Foxp3; shows how cancer develops resistance to ...

Prostate cancer often earns the label “silent killer” because it can develop and progress for years without producing noticeable symptoms. Understanding this timeline becomes crucial for men seeking ...

Researchers have identified a previously unknown inflammatory mechanism that may drive the aggressiveness and relapse of ...

Common diabetes drugs may do more than regulate blood sugar—they could also influence how cancers grow, spread, or slow down.

Radon and smoking are both known causes of lung cancer, but when someone is exposed to both, the results can be deadly.

A recent review examined how widely used treatments such as metformin, SGLT2 inhibitors, and GLP-1 receptor agonists may ...

Understanding who is at higher risk and how to minimise that risk is central to taking charge of cervical health, especially ...

A new multicenter study by researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with the Clinical Proteomic Tumor Analysis Consortium (CPTAC) and colleagues around the world, ...

A new study by researchers in Belfast is exploring how bowel cancer develops resistance to treatment. Early-onset cases of ...

The Eve appeal in partnership with North West Cancer Research, has awarded a third Fellowship to Dr Sarah Kitson, ...

Cervical cancer is largely preventable, yet HPV often shows no symptoms. Know the unusual warning signs women should never ...